Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353

1.

HIV-2 as a model to identify a functional HIV cure.

Esbjörnsson J, Jansson M, Jespersen S, Månsson F, Hønge BL, Lindman J, Medina C, da Silva ZJ, Norrgren H, Medstrand P, Rowland-Jones SL, Wejse C.

AIDS Res Ther. 2019 Sep 5;16(1):24. doi: 10.1186/s12981-019-0239-x. Review.

2.

Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort.

Nabatanzi R, Bayigga L, Cose S, Rowland Jones S, Joloba M, Canderan G, Nakanjako D.

J Infect Dis. 2019 Jul 19. pii: jiz320. doi: 10.1093/infdis/jiz320. [Epub ahead of print]

PMID:
31323092
3.

Reply to authors.

Rowland-Jones S, Yindom LM, Ferrand R.

Clin Infect Dis. 2019 Jun 27. pii: ciz522. doi: 10.1093/cid/ciz522. [Epub ahead of print] No abstract available.

PMID:
31247070
4.

History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children.

Sovershaeva E, Kranzer K, Mchugh G, Bandason T, Majonga ED, Usmani OS, Rowland-Jones S, Gutteberg T, Flægstad T, Ferrand RA, Odland JØ.

AIDS. 2019 Sep 1;33(11):1711-1718. doi: 10.1097/QAD.0000000000002265.

5.

New insights are game-changers in HIV-2 disease management - Authors' reply.

Esbjörnsson J, Månsson F, Lindman J, Rowland-Jones SL, Jansson M, Medstrand P, Norrgren H; SWEGUB CORE GROUP.

Lancet HIV. 2019 Apr;6(4):e214-e215. doi: 10.1016/S2352-3018(19)30089-X. No abstract available.

PMID:
30942185
6.

Dimorphism in the T-cell receptor constant region affects T-cell function, phenotype and HIV outcome.

Kaewpreedee P, Boonrat P, Tansiri Y, Rowland-Jones SL, Hansasuta P.

AIDS. 2019 Jul 15;33(9):1421-1429. doi: 10.1097/QAD.0000000000002187.

PMID:
30932962
7.

Effect of antiretroviral therapy on longitudinal lung function trends in older children and adolescents with HIV-infection.

Rylance S, Rylance J, McHugh G, Majonga E, Bandason T, Mujuru H, Nathoo K, Rowland-Jones S, Henrion MYR, Simms V, Ferrand RA.

PLoS One. 2019 Mar 21;14(3):e0213556. doi: 10.1371/journal.pone.0213556. eCollection 2019.

8.

Unexpectedly High Prevalence of Cytomegalovirus DNAemia in Older Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection.

Yindom LM, Simms V, Majonga ED, McHugh G, Dauya E, Bandason T, Vincon H, Rylance J, Munyati S, Ferrand RA, Rowland-Jones SL.

Clin Infect Dis. 2019 Mar 4. pii: ciy961. doi: 10.1093/cid/ciy961. [Epub ahead of print]

9.

Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort.

Nabatanzi R, Bayigga L, Cose S, Rowland-Jones S, Canderan G, Joloba M, Nakanjako D.

Clin Immunol. 2019 Apr;201:55-60. doi: 10.1016/j.clim.2019.02.010. Epub 2019 Feb 26.

10.

Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid.

Boswell MT, Rowland-Jones SL.

Clin Exp Immunol. 2019 Jun;196(3):305-317. doi: 10.1111/cei.13280. Epub 2019 Mar 21. Review.

PMID:
30773620
11.

Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.

Palm AA, Lemey P, Jansson M, Månsson F, Kvist A, Szojka Z, Biague A, da Silva ZJ, Rowland-Jones SL, Norrgren H, Esbjörnsson J, Medstrand P.

MBio. 2019 Jan 8;10(1). pii: e01245-18. doi: 10.1128/mBio.01245-18.

12.

KIR and HLA-C Genetic Polymorphisms Influence Plasma IP-10 Concentration in Antiretroviral Therapy-Naive HIV-Infected Adult Zimbabweans.

Mhandire K, Zijenah LS, Tshabalala M, Yindom LM, Mlambo T, Mhandire DZ, Musarurwa C, Duri K, Rowland-Jones S, Dandara C, Stray-Pedersen B.

OMICS. 2019 Feb;23(2):111-118. doi: 10.1089/omi.2018.0147. Epub 2019 Jan 7.

PMID:
30614763
13.

Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study.

Esbjörnsson J, Månsson F, Kvist A, da Silva ZJ, Andersson S, Fenyö EM, Isberg PE, Biague AJ, Lindman J, Palm AA, Rowland-Jones SL, Jansson M, Medstrand P, Norrgren H; Sweden and Guinea-Bissau Cohort Research Group.

Lancet HIV. 2018 Nov 1. pii: S2352-3018(18)30254-6. doi: 10.1016/S2352-3018(18)30254-6. [Epub ahead of print]

PMID:
30392769
14.

Pilot testing of an online training module about screening for acute HIV infection in adult patients seeking urgent healthcare.

Rafferty H, Chirro O, Oduor C, Wahome E, Ngoi C, van der Elst E, Berger R, Rowland-Jones S, Graham SM, Sanders EJ.

Int Health. 2019 Mar 1;11(2):93-100. doi: 10.1093/inthealth/ihy077.

15.

Low-Bias RNA Sequencing of the HIV-2 Genome from Blood Plasma.

James KL, de Silva TI, Brown K, Whittle H, Taylor S, McVean G, Esbjörnsson J, Rowland-Jones SL.

J Virol. 2018 Dec 10;93(1). pii: e00677-18. doi: 10.1128/JVI.00677-18. Print 2019 Jan 1.

16.

Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control.

Murakoshi H, Koyanagi M, Akahoshi T, Chikata T, Kuse N, Gatanaga H, Rowland-Jones SL, Oka S, Takiguchi M.

EBioMedicine. 2018 Oct;36:103-112. doi: 10.1016/j.ebiom.2018.09.022. Epub 2018 Sep 22.

17.

CD4+ cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence.

Simms V, Rylance S, Bandason T, Dauya E, McHugh G, Munyati S, Mujuru H, Rowland-Jones SL, Weiss HA, Ferrand RA.

AIDS. 2018 Sep 10;32(14):1977-1982. doi: 10.1097/QAD.0000000000001905.

18.

Killer-cell immunoglobulin-like receptors associate with HIV-1 infection in a narrow-source Han Chinese cohort.

Wang L, Zhang Y, Xu K, Dong T, Rowland-Jones S, Yindom LM.

PLoS One. 2018 Apr 17;13(4):e0195452. doi: 10.1371/journal.pone.0195452. eCollection 2018.

19.

Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak.

Andrews SM, Zhang Y, Dong T, Rowland-Jones SL, Gupta S, Esbjörnsson J.

Sci Rep. 2018 Apr 10;8(1):5743. doi: 10.1038/s41598-018-23913-2.

20.

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.

de Silva TI, Leligdowicz A, Carlson J, Garcia-Knight M, Onyango C, Miller N, Yindom LM, Hué S, Jaye A, Dong T, Cotten M, Rowland-Jones SL.

AIDS. 2018 Mar 27;32(6):709-714. doi: 10.1097/QAD.0000000000001753.

21.

Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.

Gonzalez-Martinez C, Kranzer K, McHugh G, Corbett EL, Mujuru H, Nicol MP, Rowland-Jones S, Rehman AM, Gutteberg TJ, Flaegstad T, Odland JO, Ferrand RA; BREATHE study team.

Trials. 2017 Dec 28;18(1):622. doi: 10.1186/s13063-017-2344-2.

22.

Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era.

Weatherley DAV, Boswell MT, Rowland-Jones SL.

Front Immunol. 2017 Nov 22;8:1616. doi: 10.3389/fimmu.2017.01616. eCollection 2017.

23.

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.

Yindom LM, Mendy M, Bodimeade C, Chambion C, Aka P, Whittle HC, Rowland-Jones SL, Walton R.

PLoS One. 2017 Nov 17;12(11):e0188307. doi: 10.1371/journal.pone.0188307. eCollection 2017.

24.

Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination.

Darboe F, Adetifa JU, Reynolds J, Hossin S, Plebanski M, Netea MG, Rowland-Jones SL, Sutherland JS, Flanagan KL.

Front Immunol. 2017 Sep 8;8:1092. doi: 10.3389/fimmu.2017.01092. eCollection 2017.

25.

Editorial: Immune Mechanisms Underlying the Increased Morbidity and Mortality of HIV-Exposed Uninfected (HEU) Children.

Goetghebuer T, Rowland-Jones SL, Kollmann TR.

Front Immunol. 2017 Sep 6;8:1060. doi: 10.3389/fimmu.2017.01060. eCollection 2017. No abstract available.

26.

Snapin promotes HIV-1 transmission from dendritic cells by dampening TLR8 signaling.

Khatamzas E, Hipp MM, Gaughan D, Pichulik T, Leslie A, Fernandes RA, Muraro D, Booth S, Zausmer K, Sun MY, Kessler B, Rowland-Jones S, Cerundolo V, Simmons A.

EMBO J. 2017 Oct 16;36(20):2998-3011. doi: 10.15252/embj.201695364. Epub 2017 Sep 18.

27.

Negative Correlation between Circulating CD4+FOXP3+CD127- Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory Role.

Ndure J, Noho-Konteh F, Adetifa JU, Cox M, Barker F, Le MT, Sanyang LC, Drammeh A, Whittle HC, Clarke E, Plebanski M, Rowland-Jones SL, Flanagan KL.

Front Immunol. 2017 Aug 14;8:921. doi: 10.3389/fimmu.2017.00921. eCollection 2017.

28.

Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection.

Pickering H, Teng A, Faal N, Joof H, Makalo P, Cassama E, Nabicassa M, Last AR, Burr SE, Rowland-Jones SL, Thomson NR, Roberts CH, Mabey DCW, Bailey RL, Hayward RD, de la Maza LM, Holland MJ.

Sci Rep. 2017 Aug 29;7(1):9634. doi: 10.1038/s41598-017-09193-2.

29.

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis.

Hassan AS, Hare J, Kamini G, Yindom LM, Kamali A, Karita E, Kilemba W, Price MA, Borrow P, Bjorkman P, Albert J, Kaleebu P, Allan S, Fast P, Hunter E, Gilmour J, Ndung'u T, Rowland-Jones S, Sanders EJ, Esbjornsson J.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.034. doi: 10.1093/ve/vew036.034. eCollection 2017 Mar. No abstract available.

30.

Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.

Garcia-Knight MA, Nduati E, Hassan AS, Nkumama I, Etyang TJ, Hajj NJ, Gambo F, Odera D, Berkley JA, Rowland-Jones SL, Urban B.

AIDS. 2017 Aug 24;31(13):1809-1818. doi: 10.1097/QAD.0000000000001568.

31.

Recent advances in understanding HIV evolution.

Andrews SM, Rowland-Jones S.

F1000Res. 2017 Apr 28;6:597. doi: 10.12688/f1000research.10876.1. eCollection 2017. Review.

32.

KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection?

Mhandire K, Zijenah LS, Yindom LM, Duri K, Mlambo T, Tshabalala M, Mazengera LR, Mhandire DZ, Musarurwa C, Dandara C, Rowland-Jones S, Matarira HT, Stray-Pedersen B.

OMICS. 2016 Dec;20(12):727-735.

PMID:
27930093
33.

Chronic lung disease in HIV-infected children established on antiretroviral therapy.

Rylance J, Mchugh G, Metcalfe J, Mujuru H, Nathoo K, Wilmore S, Rowland-Jones S, Majonga E, Kranzer K, Ferrand RA.

AIDS. 2016 Nov 28;30(18):2795-2803.

34.

Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.

Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V; ANRS CO5 IMMUNOVIR-2 Study Group.

J Immunol. 2016 Oct 1;197(7):2787-95. doi: 10.4049/jimmunol.1600693. Epub 2016 Aug 26.

35.

A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.

Zhang YH, Zhao Y, Rajapaksa US, Lawrence TM, Peng YC, Liu J, Xu K, Hu K, Qin L, Liu N, Sun H, Yan HP, Repapi E, Rowland-Jones S, Thimme R, McKeating JA, Dong T.

PLoS One. 2016 Jul 25;11(7):e0158037. doi: 10.1371/journal.pone.0158037. eCollection 2016.

36.

Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children.

Filteau S, Rowland-Jones S.

Front Immunol. 2016 Jun 30;7:257. doi: 10.3389/fimmu.2016.00257. eCollection 2016. Review.

37.

Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination.

Noho-Konteh F, Adetifa JU, Cox M, Hossin S, Reynolds J, Le MT, Sanyang LC, Drammeh A, Plebanski M, Forster T, Dickinson P, Ghazal P, Whittle H, Rowland-Jones SL, Sutherland JS, Flanagan KL.

Clin Infect Dis. 2016 Nov 1;63(9):1213-1226. Epub 2016 Jul 19.

38.

Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection.

Garcia-Knight MA, Slyker J, Payne BL, Pond SL, de Silva TI, Chohan B, Khasimwa B, Mbori-Ngacha D, John-Stewart G, Rowland-Jones SL, Esbjörnsson J.

Sci Rep. 2016 Jul 12;6:29536. doi: 10.1038/srep29536.

39.

HLA-C*16:01:01:02, a recently isolated HLA class I allele from Southern Africa.

Shepherd BL, Bandason T, Ferrand R, Rowland-Jones S, Yindom LM.

HLA. 2016 Jun;87(6):470-1. doi: 10.1111/tan.12800. Epub 2016 Apr 24.

PMID:
27108779
40.

Isolation of full-length HLA-C*18:02 allele in an individual from Sub-Saharan Africa.

Shepherd BL, Dauya E, Ferrand R, Rowland-Jones S, Yindom LM.

HLA. 2016 Jun;87(6):471-2. doi: 10.1111/tan.12804. Epub 2016 Apr 21.

PMID:
27098306
41.

HLA-C*06:04:02 a novel HLA-C allele isolated from donors of Southern African descent.

Shepherd BL, Ferrand R, Rowland-Jones S, Yindom LM.

HLA. 2016 May;87(5):402-3. doi: 10.1111/tan.12788. Epub 2016 Mar 31.

PMID:
27029435
42.

Changing oral vaccine to inactivated polio vaccine might increase mortality.

Fish EN, Flanagan KL, Furman D, Klein SL, Kollmann TR, Jeppesen DL, Levy O, Marchant A, Namachivayam S, Netea MG, Plebanski M, Rowland-Jones SL, Selin LK, Shann F, Whittle HC.

Lancet. 2016 Mar 12;387(10023):1054-1055. doi: 10.1016/S0140-6736(16)00661-9. No abstract available.

43.

Chikungunya: out of the tropical forests and heading our way ….

Rowland-Jones SL.

Trans R Soc Trop Med Hyg. 2016 Feb;110(2):85-6. doi: 10.1093/trstmh/trw002. No abstract available.

PMID:
26822599
44.

Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants.

Garcia-Knight MA, Nduati E, Hassan AS, Gambo F, Odera D, Etyang TJ, Hajj NJ, Berkley JA, Urban BC, Rowland-Jones SL.

PLoS One. 2015 Nov 16;10(11):e0143043. doi: 10.1371/journal.pone.0143043. eCollection 2015.

45.

Predicting the extinction of HIV-2 in rural Guinea-Bissau.

Fryer HR, Van Tienen C, Van Der Loeff MS, Aaby P, Da Silva ZJ, Whittle H, Rowland-Jones SL, de Silva TI.

AIDS. 2015 Nov 28;29(18):2479-86. doi: 10.1097/QAD.0000000000000844.

46.

Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya--a cohort study.

Nduati EW, Hassan AS, Knight MG, Muema DM, Jahangir MN, Mwaringa SL, Etyang TJ, Rowland-Jones S, Urban BC, Berkley JA.

BMC Public Health. 2015 Oct 3;15:1008. doi: 10.1186/s12889-015-2355-4.

47.

Correction. The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.

Jallow S, Leligdowicz A, Kramer HB, Onyango C, Cotten M, Wright C, Whittle HC, McMichael A, Dong T, Kessler BM, Rowland-Jones SL.

Eur J Immunol. 2015 Sep;45(9):2701. doi: 10.1002/eji.201570096. No abstract available.

48.

Full-length sequence of KIR3DL1*0310102 detected in DNA samples from West Africa.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2015 Oct;86(4):312-3. doi: 10.1111/tan.12622. Epub 2015 Jul 22.

PMID:
26198408
49.

Detection of a novel KIR3DL1*0150210 allele by sequencing.

Wang L, Zhang Y, Dong T, Rowland-Jones SL, Yindom LM.

Tissue Antigens. 2015 Oct;86(4):311. doi: 10.1111/tan.12621. Epub 2015 Jul 22.

PMID:
26198309
50.

KIR3DS1*0130109: a novel activating three-domain KIR identified using sequence-based typing.

Wang L, Zhang Y, Dong T, Rowland-Jones SL, Yindom LM.

Tissue Antigens. 2015 Sep;86(3):222-3. doi: 10.1111/tan.12617. Epub 2015 Jul 22.

PMID:
26198089

Supplemental Content

Loading ...
Support Center